Regeneron Pharmaceuticals
REGN
#231
Rank
NZ$136.65 B
Marketcap
$1,244
Share price
-0.90%
Change (1 day)
-7.02%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$84.35 M-29.37%
2023NZ$0.11 B-5.6%
2022NZ$0.12 B-53.05%
2021NZ$0.26 B5.23%
2020NZ$0.25 B414.86%
2019NZ$49.73 M-31.98%
2018NZ$73.11 M69.52%
2017NZ$43.12 M-78.72%
2016NZ$0.20 B3.03%
2015NZ$0.19 B-15.29%
2014NZ$0.23 B419.89%
2013NZ$44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$62.92 MNZ$0.25 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.32 MNZ$39.54 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$24.41 MNZ$68.86 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$81.31 MNZ$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$86.4 MNZ$0.14 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$11.17 MNZ$72.51 M๐Ÿ‡ซ๐Ÿ‡ท France